J Gastric Cancer. 2011 Mar;11(1):23-30. doi: 10.5230/jgc.2011.11.1.23. Epub 2011 Mar 31.

Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer.

Journal of gastric cancer

Huan Chun, Sung Joon Kwon

PMID: 22076198 PMCID: PMC3204474 DOI: 10.5230/jgc.2011.11.1.23

Abstract

PURPOSE: α-fetoprotein (AFP)-producing gastric cancer is a rare tumor with high rates of liver metastasis and a poor prognosis. Many studies have been performed but there have been no comprehensive investigations of the clinicopathological and prognosis.

MATERIALS AND METHODS: Six hundred ninety four patients with gastric cancer who underwent a curative gastric resection in Hanyang University Hospital from February 2001 to December 2008 were evaluated retrospectively after excluding active or chronic hepatits, liver cirrhosis and preoperative distant metastasis. Among them, thirty five patients had an elevated serum level of AFP (>7 ng/ml) preoperatively. The clinicopathological features of AFP-producing gastric cancer were analyzed.

RESULTS: There was poorer differentiation, a higher incidence of lymph node metastasis, more marked lymphatic and vascular invasion in the AFP-positive group than in the AFP-negative group. The 5-year survival rate of the AFP-positive group was significantly poorer than that in the AFP-negative group (66% vs. 80%, P=0.002). A significantly higher incidence of liver metastasis was observed in the AFP-positive group than in the AFP-negative group (14.3% vs. 3.6%, P=0.002) with a shorter median time period from the operation to the metachronous liver metastasis (3.7 months vs. 14.1 months, P=0.043). Multivariate survival analysis revealed the depth of invasion, degree of lymph node metastasis and AFP-positivity to be the independent prognostic factors.

CONCLUSIONS: AFP-producing gastric cancers have an aggressive behavior with a high metastatic potential to the liver. In addition, their clinicopathological features are quite different from the more common AFP-negative gastric cancer.

Keywords: Alpha-fetoproteins; Liver metastasis; Prognosis; Stomach neoplasms

References

1. J Surg Oncol. 2010 Sep 1;102(3):249-55 - PubMed
2. Pathol Int. 2002 Jan;52(1):46-53 - PubMed
3. Dig Surg. 2002;19(5):359-65; discussion 365 - PubMed
4. Hum Pathol. 2007 Jun;38(6):857-63 - PubMed
5. Scand J Clin Lab Invest. 1956;8(2):174 - PubMed
6. Cancer. 1996 Jun 1;77(11):2217-22 - PubMed
7. Dig Dis. 1995 Mar-Apr;13(2):81-91 - PubMed
8. Oncology. 2000 Aug;59(2):145-51 - PubMed
9. Surg Today. 1999;29(10):1075-8 - PubMed
10. Presse Med. 1970 Jun 6;78(28):1277-8 - PubMed
11. Nihon Geka Gakkai Zasshi. 1990 Oct;91(10):1574-80 - PubMed
12. J Clin Invest. 1966 Nov;45(11):1826-38 - PubMed
13. Cancer Gene Ther. 1996 Nov-Dec;3(6):393-404 - PubMed
14. Am J Gastroenterol. 1992 Mar;87(3):321-5 - PubMed
15. Acta Pathol Jpn. 1993 Nov;43(11):654-61 - PubMed
16. Am J Gastroenterol. 1990 Nov;85(11):1480-5 - PubMed
17. Gastroenterology. 1976 Sep;71(3):497-9 - PubMed
18. Am J Gastroenterol. 1999 Jun;94(6):1658-63 - PubMed
19. Cancer Res. 1972 May;32(5):979-82 - PubMed
20. Gastroenterol Jpn. 1989 Jun;24(3):325-31 - PubMed
21. Cancer Res. 1975 Apr;35(4):991-6 - PubMed
22. Kurume Med J. 1997;44(4):339-48 - PubMed
23. Hinyokika Kiyo. 1995 May;41(5):387-9 - PubMed
24. Surg Today. 1997;27(6):563-6 - PubMed

Publication Types

• Journal Article